Organogenesis Holdings (ORGO) Assets (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Assets of $520.0 million for Q1 2026, up 11.25% year-over-year from $467.4 million in Q1 2025, and down 13.15% quarter-over-quarter from $598.7 million in Q4 2025.
Organogenesis Holdings (ORGO) Assets (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Assets history runs 12 years deep, the most recent figure standing at $520.0 million for Q1 2026.
- In Q1 2026, Assets rose 11.25% year-over-year to $520.0 million; the TTM figure through Mar 2026 stood at $520.0 million (up 11.25% YoY), while the FY2025 annual figure was $598.7 million, up 20.25% from the prior year.
- Assets for Q1 2026 stood at $520.0 million, down from $598.7 million in the prior quarter.
- The five-year high for Assets was $598.7 million in Q4 2025, with the low at $436.3 million in Q1 2022.
- The 5-year median for Assets is $458.5 million (2024), against an average of $471.8 million.
- The sharpest annual moves came in 2022 and 2024: Assets jumped 36.68% in 2022, then dropped 3.53% in 2024.
- Organogenesis Holdings' Assets stood at $449.4 million in 2022, then grew by 2.37% to $460.0 million in 2023, then climbed by 8.23% to $497.9 million in 2024, then gained by 20.25% to $598.7 million in 2025, then fell by 13.15% to $520.0 million in 2026.
- Business Quant data shows ORGO's Assets at $520.0 million in Q1 2026, $598.7 million in Q4 2025, and $509.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 6.18 Bn |
| 10 | Organogenesis Holdings | 239.98 Mn | 193.13 Mn | 20.08 Mn | 406.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 406.45 Mn |
| Mar 31, 2026 | 519.99 Mn |
| Dec 31, 2025 | 598.73 Mn |
| Sep 30, 2025 | 509.83 Mn |
| Jun 30, 2025 | 461.13 Mn |
| Mar 31, 2025 | 467.39 Mn |
| Dec 31, 2024 | 497.89 Mn |
| Sep 30, 2024 | 446.30 Mn |
| Jun 30, 2024 | 443.16 Mn |
| Mar 31, 2024 | 458.48 Mn |
| Dec 31, 2023 | 460.03 Mn |
| Sep 30, 2023 | 462.65 Mn |
| Jun 30, 2023 | 450.31 Mn |
| Mar 31, 2023 | 446.11 Mn |
| Dec 31, 2022 | 449.36 Mn |
| Sep 30, 2022 | 457.27 Mn |
| Jun 30, 2022 | 456.36 Mn |
| Mar 31, 2022 | 436.27 Mn |
| Dec 31, 2021 | 443.26 Mn |
| Sep 30, 2021 | 370.42 Mn |